TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
MIRAPHARM AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
13
|
10
|
10 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
3
|
403
|
5 |
| EBITDA |
-1
|
2
|
5 |
| Total assets |
185
|
413
|
24 |
| Current assets |
155
|
383
|
12 |
| Current liabilities |
5
|
2
|
3 |
| Equity capital |
180
|
411
|
22 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
1
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
97.3%
|
99.5%
|
91.7% |
| Turnover per employee | 13 | ||
| Profit as a percentage of turnover |
23.1%
|
4030.0%
|
50.0% |
| Return on assets (ROA) |
1.6%
|
97.6%
|
20.8% |
| Current ratio |
3100%
|
19150.0%
|
400% |
| Return on equity (ROE) |
1.7%
|
98.1%
|
22.7% |
| Change turnover |
3
|
1
|
-1 |
| Change turnover % |
30%
|
14%
|
-10% |
| Chg. No. of employees |
1
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.